MedPath

PIPERACILINA/TAZOBACTAM KABI 4 g/0,5 g POLVO PARA SOLUCION PARA PERFUSION EFG

PIPERACILINA/TAZOBACTAM KABI 4 g/0,5 g POLVO PARA SOLUCION PARA PERFUSION EFG

Commercialized
Register Number

71601

Prescription Type

Uso Hospitalario

Authorization Date

Jan 26, 2010

Dosage Form

POLVO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number71601
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

PIPERACILINAActive
Quantity: 4,0 g
Name: PIPERACILINA
TAZOBACTAMActive
Quantity: 500,0 mg
Name: TAZOBACTAM

ATC CLASSIFICATION (3)

J01C
J01CR
J01CR05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.